PipeBio Analysis
What is PipeBio?
PipeBio provides a cloud-based bioinformatics platform for analyzing antibody sequences, automating workflows, and managing large-scale sequencing data for scientists and bioinformaticians.
Employees
10
Founded
2020
Revenue
<$5M
Business Model
Subscription-based model for accessing bioinformatics software and services.
Company Stage
Pre-Seed
Investors
- Acequia Capital
- Y Combinator
- InnoFounder
- byFounders
YC Batch
W21
Product Features & Capabilities
- Bioinformatics software for BCR, TCR, VHH, scFv, peptide sequence analysis, automated workflows for NGS antibody repertoires, sequence database and storage, annotation and liability identification, clustering and comparison of samples, visualization with interactive charts, functional assay data int
Pricing
-
Academic Plan (up to 5 named users)
- For academic and non-commercial institutions
- Free trial available
- Features include Sanger sequence analysis, NGS analysis, interactive visualization, clustering, custom germlines, and sequence editing.
-
Commercial Plan (up to 5 or bespoke n
Who are the founders of PipeBio
OB
Owen Bodley
CTO
JB
Jannick Bendtsen
Founder
Market Focus
PipeBio primarily focuses on the bioinformatics industry, specifically in the analysis of antibody sequences and the automation of workflows for managing large-scale sequencing data.
Competitors Overview
PipeBio operates in the bioinformatics software market, focusing on antibody sequence analysis. Its main competitors include:
- Geneious: This platform provides comprehensive bioinformatics solutions for molecular sequence analysis, interpretation, and application. Geneious is known for its us
Company Pricing
-
Academic Plan (up to 5 named users)
- For academic and non-commercial institutions
- Free trial available
- Features include Sanger sequence analysis, NGS analysis, interactive visualization, clustering, custom germlines, and sequence editing.
-
Commercial Plan (up to 5 or bespoke n
See something that needs updating? Suggest edits to this profile.